Evidence map›Paper›PMID 38928679›Full record

ArticleDiagnostics (Basel, Switzerland)2024

ML Models Built Using Clinical Parameters and Radiomic Features Extracted from

Luca Urso, Corrado Cittanti, Luigi Manco, Naima Ortolan, Francesca Borgia, Antonio Malorgio, Giovanni Scribano, Edoardo Mastella, Massimo Guidoboni, Antonio Stefanelli and 2 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Challenges and unmet needs of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Machine Learning Models Derived from [Bioengineering (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luca UrsoDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-3007-3898
Corrado CittantiDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-5117-804X
Luigi MancoMedical Physics Unit, University Hospital of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-9338-8638
Naima OrtolanDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0003-1985-6311
Francesca BorgiaDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-9753-9699
Antonio MalorgioU.O.C. Radiotherapy, University Hospital of Ferrara, 44124 Ferrara, Italy.
Giovanni ScribanoDepartment of Physics and Earth Science, University of Ferrara, 44121 Ferrara, Italy.ORCID 0009-0008-5391-3176
Edoardo MastellaMedical Physics Unit, University Hospital of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-1913-3976
Massimo GuidoboniDepartment of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
Antonio StefanelliU.O.C. Radiotherapy, University Hospital of Ferrara, 44124 Ferrara, Italy.ORCID 0000-0003-4444-0668
Alessandro TurraMedical Physics Unit, University Hospital of Ferrara, 44124 Ferrara, Italy.
Mirco BartolomeiNuclear Medicine Unit, Onco-Hematology Department, University Hospital of Ferrara, 44124 Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligometastatic patients at [

methodsOligorecurrent patients (≤5 lesions) at

resultsA total of 46 metastases were selected and segmented in 29 patients. BCR after MDT occurred in 20 (69%) patients after 2 years of follow-up. In total, 73 and 33 robust RFTs were selected from CT and PET datasets, respectively. PET ML Models showed better performances than CT Models for discriminating BCR after MDT, with Stochastic Gradient Descent (SGD) being the best model (AUC = 0.95; CA = 0.90).

conclusionML Models built using clinical parameters and CT and PET RFts extracted via

Indexed as

18F-choline PETbiochemical recurrencemachine learningmetastasis-directed therapy (MDT)prostate cancerradiomics

Identifiers

PMID38928679
PMCPMC11202947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.